Combined chemotherapy with cisplatin, etoposide, and irinotecan versus topotecan alone as second-line treatment for patients with sensitive relapsed small-cell lung cancer (JCOG0605): a multicentre, open-label, randomised phase 3 trial.
暂无分享,去创建一个
K. Mori | Y. Ohe | K. Kiura | M. Satouchi | K. Goto | N. Yoshimura | M. Nishio | Toshiaki Takahashi | T. Seto | T. Tamura | K. Nakagawa | Hiroshi Tanaka | T. Hida | F. Imamura | K. Takeda | T. Shibata | T. Sawa | H. Okamoto | T. Kozuki